---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-078742"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2022-12-09T23:59:59+00:00"
generated_at: "2026-06-21T06:59:38.602596+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Larkspur Health Acquisition Corp. stockholders approve ZyVersa merger; 7.7M shares redeemed

## Summary
- Stockholders approved business combination with ZyVersa Therapeutics: 6,543,525 for, 785,791 against.
- Approved charter amendments, 2022 Omnibus Incentive Plan, and Nasdaq issuance proposals.
- 7,667,029 shares tendered for redemption, ~76% of outstanding shares (10,029,221).
- Special meeting held Dec 8, 2022; 73.08% quorum achieved.

## SEC filing metadata
- accession: 0001213900-22-078742
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2022-12-09T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/0001213900-22-078742-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/ea169867-8k_larkspur.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-078742
- JSON: https://secwatch.observer/filing/0001213900-22-078742.json
- Plain text: https://secwatch.observer/filing/0001213900-22-078742.txt

## Key facts
- Shareholder Votes
  ZyVersa Therapeutics, Inc. shareholders approved Approve exclusive forum provision for certain actions in Delaware courts. at the 2022-12-08 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2022-12-08
  source text: Vote to approve the Forum Selection Proposal: Total Votes For Total Votes Against Abstentions 6,011,855 1,317,461 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/0001213900-22-078742-index.htm
- Shareholder Votes
  ZyVersa Therapeutics, Inc. shareholders approved Approve increase in authorized capital stock to 111,000,000 shares. at the 2022-12-08 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2022-12-08
  source text: Vote to approve the Authorized Shares Proposal: Total Votes For Total Votes Against Abstentions 6,526,282 803,034 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/0001213900-22-078742-index.htm
- Shareholder Votes
  ZyVersa Therapeutics, Inc. shareholders approved Approve amendment to require 66 2/3% vote to amend bylaws. at the 2022-12-08 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2022-12-08
  source text: Vote to approve the Bylaws Amendment Proposal: Total Votes For Total Votes Against Abstentions 6,480,158 849,158 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/0001213900-22-078742-index.htm
- Shareholder Votes
  ZyVersa Therapeutics, Inc. shareholders approved Approve general amendments to charter including name change, purpose, removal of blank check provisions, and removal of stockholder action by written consent. at the 2022-12-08 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2022-12-08
  source text: Vote to approve the General Amendments Proposal: Total Votes For Total Votes Against Abstentions 6,526,282 803,034 0 1
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/0001213900-22-078742-index.htm
- Shareholder Votes
  ZyVersa Therapeutics, Inc. shareholders approved Approve amendment to set quorum at 33 1/3% of voting power. at the 2022-12-08 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2022-12-08
  source text: Vote to approve the Quorum Standard Proposal: Total Votes For Total Votes Against Abstentions 6,526,283 803,033 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/0001213900-22-078742-index.htm
- Shareholder Votes
  ZyVersa Therapeutics, Inc. shareholders approved Approve adoption of Business Combination Agreement with ZyVersa Therapeutics, Inc. at the 2022-12-08 meeting.
  - Proposal: merger approval
  - Outcome: passed
  - Meeting: 2022-12-08
  source text: Vote to approve the Business Combination Proposal: Total Votes For Total Votes Against Abstentions 6,543,525 785,791 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/0001213900-22-078742-index.htm
- Shareholder Votes
  ZyVersa Therapeutics, Inc. shareholders approved Approve amendment to require 66 2/3% vote to amend certain charter provisions. at the 2022-12-08 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2022-12-08
  source text: Vote to approve the Supermajority Voting Standard Proposal: Total Votes For Total Votes Against Abstentions 6,480,157 849,159 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/0001213900-22-078742-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.